1. Home
  2. LEGH vs AUTL Comparison

LEGH vs AUTL Comparison

Compare LEGH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LEGH

Legacy Housing Corporation (TX)

HOLD

Current Price

$22.63

Market Cap

528.7M

ML Signal

HOLD

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.79

Market Cap

407.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEGH
AUTL
Founded
2005
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
528.7M
407.2M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
LEGH
AUTL
Price
$22.63
$1.79
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$25.00
$8.50
AVG Volume (30 Days)
65.9K
1.3M
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$164,567,000.00
$10,120,000.00
Revenue This Year
$11.90
$80.32
Revenue Next Year
$6.58
$53.96
P/E Ratio
$48.00
N/A
Revenue Growth
N/A
496.00
52 Week Low
$18.29
$1.18
52 Week High
$29.45
$2.70

Technical Indicators

Market Signals
Indicator
LEGH
AUTL
Relative Strength Index (RSI) 56.78 63.47
Support Level $20.53 $1.25
Resistance Level $24.11 $1.93
Average True Range (ATR) 1.06 0.12
MACD 0.05 0.01
Stochastic Oscillator 66.08 70.54

Price Performance

Historical Comparison
LEGH
AUTL

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: